CurrentmhnPolicy CP.BH.300

Biofeedback for Behavioral Health Disorders

Customize your policy alerts

Sign up for mhn Policy CP.BH.300 alerts

Get alerted when Policy CP.BH.300 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Defines medical necessity criteria, limits, and review process for biofeedback used as an adjunctive treatment for anxiety disorders and PTSD for members/enrollees of Centene-affiliated behavioral health plans.

Policy Summary

Payermhn

PolicyBiofeedback for Behavioral Health Disorders

Policy CodePolicy CP.BH.300

Change TypeNo material changes noted

Effective Date

Next Review Date

Key ActionObtain prior authorization for an initial course of up to 25 biofeedback sessions by documenting diagnosis, severity, participation, and an individualized treatment and transition plan.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

25initial medically necessary sessions allowed

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentmhnPolicy CP.BH.300

Biofeedback for Behavioral Health Disorders

Customize your policy alerts

Sign up for mhn Policy CP.BH.300 alerts

Get alerted when Policy CP.BH.300 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

Payermhn

PolicyBiofeedback for Behavioral Health Disorders

Policy CodePolicy CP.BH.300

Change TypeNo material changes noted

Effective Date

Next Review Date

Key ActionObtain prior authorization for an initial course of up to 25 biofeedback sessions by documenting diagnosis, severity, participation, and an individualized treatment and transition plan.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

25initial medically necessary sessions allowed

continuation (case-by-case)

25%min improvement for continuation review

50%discharge symptom reduction threshold

anxiety, PTSDeligible diagnoses

Coverage criteria for biofeedback

Initial therapy (up to 25 sessions)

Covered when ALL of the following are met

Initial coverage criteria: A. Diagnosis of anxiety disorder or PTSD (DSM V-TR); B. Significant symptoms interfering with at least one life area measured by a widely recognized validated standardized severity scale focused on the symptom profile; C. Member motivated and able to actively participate in the treatment plan, including home practice and follow-through; D. A comprehensive treatment plan includes biofeedback as an adjunctive intervention in addition to other primary evidence-based interventions; E. The condition is appropriate for biofeedback (existing pathology does not prevent success); F. Evidence that standard evidence-based outpatient treatments (psychotherapy and/or medication management) are insufficient to treat the condition safely and effectively; G. Readily identifiable response measurable by a symptom-specific validated standardized scale; H. Biofeedback training performed by a physician or qualified non-physician practitioner with biofeedback training and certification (e.g., nurse practitioners, physician assistants, psychologists, qualified mental health professionals, or applicable biofeedback technicians); I. Individualized treatment plan with clearly stated realistic goals and objectives; J. Treatment structured to achieve optimum documented expected benefit; K. Documented planned transition out of biofeedback from the start of treatmentall

Continuation therapy (additional up to 20 sessions; case-by-case review)

Reviewed by Medical Director when ALL of the following are met

Continuation criteria: A. Initial criteria are still met; B. Frequency of sessions is scheduled at a rate consistent with the presenting symptoms and showing results; C. Progress demonstrated by at least a 25% reduction in severity compared to the last review; D. When medically necessary, appropriate psychopharmacological intervention is provided; E. Documented planned transition out of biofeedback from the start of treatment that (1) identifies a plan ensuring the member can continue biofeedback-learned techniques independently after sessions end and (2) identifies a goal with a clear and reasonable score range on a validated scale demonstrating meaningful progressall

Discontinuation / No longer medically necessary

Biofeedback is no longer medically necessary when ANY of the following are met

Discharge criteria: A. Documented goals and objectives have been achieved; B. Member no longer meets initiation or continuation criteria, or symptom severity has dropped by 50%; C. Member not engaging in treatment despite multiple documented attempts to address non-participation; D. Member refuses treatment; E. Member not making progress toward treatment goals and there is no reasonable expectation of progress with this treatment approach; F. It is reasonably predicted that continuing improvement can occur after discontinuation of biofeedback with ongoing psychotherapy, medication management and/or community supportany

The policy states there is insufficient evidence in the published peer‑reviewed literature to support the use of biofeedback for any behavioral health diagnosis other than those specified as medically necessary in this policy. This exclusion limits coverage to the diagnoses identified in the policy (see coverage criteria) and indicates other behavioral health indications are not supported by the available evidence.

The policy explicitly notes there is insufficient evidence to support neurosound/biosound treatment, which is commonly billed under neurofeedback procedure codes. This statement was added and clarified in the policy revision history and reflects the policy authors’ determination that published peer‑reviewed data do not support neurosound/biosound efficacy for behavioral health indications.

Per the policy, biofeedback for behavioral health diagnoses other than anxiety disorders and PTSD is not supported by published peer‑reviewed literature. As a result, such uses are considered outside the scope of medical necessity under this policy.

Relevant procedure and billing codes

Referenced CPT codesCPT

90901	Biofeedback training by any modality
90875	30 minutes of individual psychophysiological therapy incorporating biofeedback training
90876	45 minutes of individual psychophysiological therapy incorporating biofeedback training by any modality (face-to-face with the patient), with psychotherapy

Referenced CPT codesCPT

90901	Biofeedback training by any modality
90875	30 minutes of individual psychophysiological therapy incorporating biofeedback training
90876	45 minutes of individual psychophysiological therapy incorporating biofeedback training by any modality (face-to-face with the patient), with psychotherapy

Authorization, documentation, and actions required by providers

Prior Authorization

Prior Authorization Required — Initial Authorization Criteria

Initial authorization: Up to 25 sessions may be authorized when ALL of the following are met: diagnosis of anxiety disorder or PTSD (DSM V-TR); significant symptoms interfering with functioning in at least one life area measured by a validated standardized severity scale; member is motivated and can actively participate (including home practice); biofeedback is included as an adjunctive intervention within a comprehensive treatment plan alongside other primary evidence-based interventions; condition is appropriate for biofeedback; standard evidence-based outpatient treatments (psychotherapy and/or medication management) are considered insufficient or not tolerated; there is a readily identifiable response measurable by a symptom-specific validated standardized scale; biofeedback provided by appropriately trained/certified clinician or technician; individualized treatment plan with realistic goals/objectives; treatment structured for documented expected benefit; and a planned transition out of biofeedback documented from the start of treatment.

Authorization: Initial authorization up to 25 sessions when all initiation criteria met
Adjunctive requirement: Biofeedback must be part of a comprehensive plan and adjunctive to primary evidence-based interventions
Provider qualifications: Performed by physician or qualified non-physician practitioner with biofeedback training/certification
Documentation required: Individualized treatment plan, validated severity scale baseline, measurable goals, planned transition out of biofeedback

Background and evidence summary

Biofeedback is a therapeutic technique that provides real‑time physiological monitoring (for example, heart rate, respiration, muscle tension, and EEG) to teach self‑regulation skills. The policy recognizes evidence from meta‑analyses and systematic reviews supporting effectiveness for anxiety disorders and PTSD in select studies, but it also highlights significant limitations: protocols and regulation are variable, implementation lacks standardization, and further research is needed. The policy revisions clarify coverage mechanics (initial authorization up to 25 sessions with case‑by‑case review for up to an additional 20 sessions) and reinforce that continued coverage requires documented progress and transition planning. Overall, while biofeedback can be a useful adjunctive intervention when criteria are met, the evidence base is limited outside the specified diagnoses and programmatic safeguards (diagnostic limits, validated severity scales, treatment and transition planning, and qualified providers) are required for authorization.

Definitions

Biofeedback — Definition

DefinitionTherapeutic technique using instruments to monitor physiological activity (brainwaves, heart rate, respiration, muscle tension, skin temperature) and provide real-time feedback to develop self-regulation skills.

Typical monitored signalsBrainwave patterns (EEG), heart rate/heart rate variability (HR/HRV), respiration, muscle tension (EMG), skin temperature.

PurposeFacilitates voluntary control of physiological functions to support improved health and behavioral outcomes.

Providers who may deliverPhysicians, nurse practitioners, physician assistants, qualified mental health professionals, psychologists, and trained biofeedback technicians under policy requirements.

Relation to other policiesSee CP.MP.168 for biofeedback for non-behavioral health diagnoses (policy contingent on member benefit).

Level of care applicability

Included biofeedback modalities

Biofeedback (including HRV, neurofeedback)

Modality use: Used as adjunctive therapy by trained clinicians; evidence supports HRV biofeedback and neurofeedback for PTSD and anxiety in select studies, but protocols and regulation are variable and ongoing research is neededall

Visit and session limits

biofeedback sessions — initial limit

Initial session limitUp to 25 sessions of initial behavioral health-related biofeedback are medically necessary when all initiation criteria are met.

Eligible diagnosesAnxiety disorders or post-traumatic stress disorder (DSM V-TR) as listed in policy initiation criteria.

Required documentationIndividualized treatment plan with realistic goals, validated baseline severity scale, and documented planned transition out of biofeedback from the start.

Adjunctive useBiofeedback must be included as an adjunctive intervention in addition to other primary evidence-based outpatient treatments.

biofeedback sessions — additional continuation

Continuation session limitUp to an additional 20 sessions may be approved on a case-by-case basis after Medical Director review.

Policy Summary

Payermhn

PolicyBiofeedback for Behavioral Health Disorders

Policy CodePolicy CP.BH.300

Change TypeNo material changes noted

Effective Date

Next Review Date

Key ActionObtain prior authorization for an initial course of up to 25 biofeedback sessions by documenting diagnosis, severity, participation, and an individualized treatment and transition plan.

SourceLink

On This Page

Prior Authorization

Continuation Authorization — Case-by-Case Review

Continuation: Up to 20 additional sessions may be reviewed case-by-case by a Medical Director when ALL of the following are documented: initial criteria remain met; session frequency is appropriate to symptoms and progress; measurable progress is demonstrated (≥25% reduction in severity since last review); when indicated, appropriate psychopharmacology is provided; and a documented planned transition out of biofeedback remains in place with a clear goal and validated scale target. Discontinue or discharge when any one of the discontinuation triggers is met (see discontinuation callout).

Continuation requests reviewed by Medical Director
Progress threshold: ≥25% reduction in severity since last review
Must document ongoing transition plan and validated-scale goal

Documentation Required

Adjunctive Requirement

Adjunctive requirement: Biofeedback must be used as an adjunctive intervention within a comprehensive treatment plan that includes primary evidence-based treatments (e.g., psychotherapy and/or medication management). Biofeedback should be considered only when standard outpatient evidence-based treatments are insufficient to treat the member's condition safely and effectively or are not tolerated. Do not authorize biofeedback as a standalone replacement for primary evidence-based therapies.

Biofeedback must be adjunctive to primary evidence-based interventions
Standard outpatient treatments must be considered insufficient or not tolerated prior to authorizing biofeedback
Do not substitute biofeedback for psychotherapy or medication management

Documentation Required

Required Documentation

Required documentation: Maintain and submit an individualized treatment plan with clearly stated realistic goals and objectives, baseline and serial scores from a validated symptom-specific standardized scale to demonstrate response, documentation that member can participate (including home practice expectations), evidence that standard treatments were attempted or are insufficient/intolerable, clinician qualifications/certification in biofeedback, and a documented planned transition out of biofeedback from treatment initiation.

Individualized treatment plan with realistic goals/objectives
Baseline and follow-up validated scale scores to show progress
Documentation of prior standard treatments and reasons biofeedback is adjunctive
Planned transition out of biofeedback documented at start of treatment
Provider biofeedback training/certification

Denial Risk

Discontinuation Triggers

Triggers for discontinuation: Discontinue and discharge from biofeedback when any one of the following occurs: documented goals/objectives achieved; member no longer meets initiation or continuation criteria or symptom severity has dropped by 50%; member is not engaging in treatment despite multiple documented attempts to address non-participation; member refuses treatment; or member is not making progress and there is no reasonable expectation of benefit from continued biofeedback.

Goals achieved
No longer meeting initiation/continuation criteria or ≥50% symptom reduction
Non-engagement despite documented outreach
Refusal of treatment
Lack of reasonable expectation of progress

Continuation review requirementMedical Director review must confirm initial criteria still met and session frequency appropriate to symptoms and progress.

Minimum demonstrated improvementAt least a 25% reduction in severity compared to the last review is required to support continuation.

Transition planningDocumented planned transition out of biofeedback from the start, including a plan for independent continuation of learned techniques and a measurable goal on a validated scale.